PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2015 | $3,071,000 | -74.0% | 518,804 | -53.1% | 0.00% | -78.6% |
Q1 2015 | $11,834,000 | +130.9% | 1,106,994 | +102.8% | 0.01% | +133.3% |
Q4 2014 | $5,125,000 | +20.9% | 545,839 | -1.1% | 0.01% | +20.0% |
Q3 2014 | $4,239,000 | -16.1% | 551,900 | -1.9% | 0.01% | -16.7% |
Q2 2014 | $5,053,000 | – | 562,746 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 2,484,649 | $7,330,000 | 8.59% |
Avoro Capital Advisors LLC | 5,144,916 | $15,178,000 | 5.23% |
Broadfin Capital, LLC | 6,090,829 | $17,968,000 | 1.10% |
Aisling Capital LLC | 2,010,000 | $5,930,000 | 1.02% |
Healthcare Value Capital, LLC | 150,000 | $443,000 | 0.73% |
ACUTA CAPITAL PARTNERS, LLC | 434,300 | $1,281,000 | 0.61% |
WALL STREET ASSOCIATES | 696,300 | $2,054,000 | 0.58% |
SEARLE & CO. | 172,500 | $500,000 | 0.48% |
Elk Creek Partners, LLC | 2,253,667 | $6,648,000 | 0.47% |
KOPP INVESTMENT ADVISORS LLC | 315,293 | $931,000 | 0.46% |